Sittner & Nelson, LLC Sarepta Therapeutics, Inc. Transaction History
Sittner & Nelson, LLC
- $219 Million
- Q3 2024
A detailed history of Sittner & Nelson, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sittner & Nelson, LLC holds 75 shares of SRPT stock, worth $8,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$8,734
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.1MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.04 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$729 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$508 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$497 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.2B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...